Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Clinical trial NCT01696643 · TERMINATED
Trial details
- NCT number
- NCT01696643
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-12
- Primary completion
- 2014-07-21
- Enrollment
- 1407
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.